Alphabet Inc (NASDAQ:GOOG) is expected to surpass Street expectations when it reports its earnings after market on April 25.
The tech giant should outperform revenue estimates, particularly in the search and YouTube segments, according to Bank of America.
AstraZeneca PLC (LSE:AZN)’s first-quarter results were thoroughly welcomed by the market. So much so, that its valuation briefly surpassed oil major Shell to become Britain’s most valuation corporation.
With the stock now 26% higher since mid-February, the question is this: Has AstraZeneca peaked, or is there more gas in the tank?
Junior gold miners listed in London have had a good run since the start of the year, outperforming the bullion comfortably in most cases, notes broker Liberum.
Endeavour is up 22% and Centamin 35%, though Caledonia has disappointed as it hit some unexpected problems at its Blanket mine in Zimbabwe.
The year-to-date fall in the share price of Keywords Studios PLC (AIM:KWS, OTC:KYYWF), a mid-cap service provider to the gaming industry, is 'excessively pessimistic', according to a leading investment bank.
The stock has fallen 31% in that time with the downturn attributed to growing concerns around AI disruption, particularly impacting its Globalise division, which saw a 13% year-over-year decline in the second half of 2023.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) reported a robust first quarter, signalling significant operational improvements under its new leadership, according to research by UBS.
This comes after a year marked by challenges, notably in the US nutrition sector which had affected previous quarterly performances.
Broker WH Ireland upgraded its valuation of Canada-focused oil and gas company i3 Energy PLC while providing positive comments on recent developments.
"We perceive the company is bulking up for that significant growth opportunity for which scale, and commensurate financial strength, are the name of the game," said WH Ireland.
Jefferies has affirmed a positive outlook for J Sainsbury PLC (LSE:SBRY) following the grocer's strong performance in the fourth quarter of the 2023/2024 fiscal year.
Despite providing a wide profit forecast range for 2024/2025, Jefferies believes that the higher end is achievable, given a potentially favourable consumer environment.
Aviva’s strategy day for its health business yesterday was enlightening said analysts, but ultimately it represents a small part of the business.
UK Health accounts for 5% of operating profit and is expected to grow at a 15% CAGR through 2026 to £ 100 million, though Citi notes this was a third higher than its models.
UBS has restated its 'sell' recommendation for shares in BT Group PLC citing concerns over its subsidiary Openreach, which manages the United Kingdom's digital network infrastructure.
The investment bank's latest analysis assesses the challenges the business faces in maintaining its dominant position in the domestic broadband market - and thinks could lose as many as one million lines in the financial year 2025.
London-listed pharmaceuticals company Indivior PLC (LSE:INDV) has, as anticipated, confirmed that it will move its primary listing to the US.
Shareholders still need to approve the transfer, though this will be seen as a formality given the previously signalled support from major shareholders.